DANISH BIO – DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately four "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

News

Nykode Therapeutics ASA: Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy 11 June 2024

Oslo, Norway, June 11, 2024 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical... Read more

NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients 11 June 2024

Aarhus, Denmark, 11 June 2024 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing... Read more

LOPHORA SUBMITS CLINICAL TRIAL AUTHORISATION (CTA) APPLICATION TO THE FRENCH MEDICINES AGENCY (ANSM) FOR LEAD CNS DRUG LPH-5. 31 May 2024

Lophora, a clinical-stage CNS drug discovery company developing novel, next generation 5HT2ARA medicines... Read more

Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer 14 May 2024

Oslo, Norway, May 14, 2024 – Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical... Read more

Scandion confirms positive final Phase Ib data from PANTAX trial with SCO-101 13 May 2024

Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating... Read more

Data from the first human study demonstrate excellent performance of Zerion Pharma’s Dispersome® technology 13 May 2024

May 13, 2024 (COPENHAGEN, Denmark). Zerion Pharma A/S (“ZERION”) today announces positive results... Read more

Nyheder

BioFIT and MedFIT – 3-4 December 2024 – discount rate of 20% 06 May 2024

We are happy to tell you that we have entered cooperation with BioFIT and MedFIT for the 2024 conference... Read more

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer 02 May 2024

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR),... Read more

NLSDays Nordic Star Pitch Competition is NOW OPEN for applications 01 May 2024

As Dansk Biotek has been a supporter for NLSDays 2024 in Malmö, I’m happily sharing with you that... Read more

Copyright 2024 DANISH BIO – DANSK BIOTEK. All rights reserved.

created by: Mastafu Design